drugset / Trial / NCT00917241

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

NCT00917241

Phase 4 Completed 218 enrolled Xiao-Ming Mao
RandomizedParallel-groupOpen-labelTreatment

Summary

Antithyroid drugs are widely used in treatment of Graves' disease (GD), but after therapy withdrawal, relapse rate is very high. The aim this trail is to evaluate the effects of intrathyroid injection of dexamethasone combined with antithyroid drugs on patients with newly diagnosed GD.

Timeline

Start
2004-06
Primary completion
2008-12
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 5 mg Other
Background Methimazole Small molecule 20 mg

Indications